3137 results for «921»

Filter By

3137 results

Mitral TEER in challenging scenarios - Part 2

21 May 2025 – From EuroPCR 2025

This session focuses on challenging scenarios encountered during mitral transcatheter edge-to-edge repair (TEER). Learn about management of complications such as haemolysis, device malfunctions, and complex vascular access issues, supported by instructive case presentations including bailout strategies in cardiogenic shock and infective endocarditis.

Mitral TEER in challenging scenarios - Part 2

Imaging-based strategies for complication management in STEMI

21 May 2025 – From EuroPCR 2025

Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.

Imaging-based strategies for complication management in STEMI

Complex multivessel disease - LIVE Case

21 May 2025 – From EuroPCR 2025

An 89-year-old male patient presented with stable angina, preserved LV function and some risk factors such as hypertension and diabetes. CT scan and angiography revealed occlusion of proximal RCA and bifurcation lesions on LAD and circumflex (medina 1,1,1). Operators treated the bifurcation lesions with provisional stenting.
Regarding...

Complex multivessel disease - LIVE Case

Complication management during mitral TEER procedures

21 May 2025 – From EuroPCR 2025

Explore complex case scenarios of complication management during mitral TEER procedures. This session covers haemodynamic challenges, thrombotic events, device malfunctions, and rare embolisation incidents, providing practical insights into effective bailout techniques and procedural problem-solving.

Complication management during mitral TEER procedures

Which valve is best for my patient?

21 May 2025 – From EuroPCR 2025

This session guides clinicians in selecting the most appropriate transcatheter aortic valve tailored to individual patient characteristics. Through diverse case discussions, including patients with coronary artery disease, small anatomies, bicuspid valves, and surgical bioprostheses, it elucidates decision-making processes and planning for complex TAVI anatomies.

Which valve is best for my patient?

TAVI for aortic regurgitation: on-label and off-label use

21 May 2025 – From EuroPCR 2025

This session reviews on-label and off-label applications of transcatheter aortic valve implantation (TAVI) for treating aortic regurgitation. Examine complex cases including TAVI in patients with aortic dissection, cardiogenic shock, and valve-in-valve interventions, highlighting innovative procedural approaches and bailout strategies.

TAVI for aortic regurgitation: on-label and off-label use

Current DCB practice: from lesion preparation to follow-up

21 May 2025 – From EuroPCR 2025

Explore current best practices in drug-coated balloon (DCB) angioplasty from lesion preparation to follow-up. This session discusses common indications, management of dissections and complications, and shares practical tips and case examples, equipping clinicians with comprehensive knowledge to optimize DCB use in contemporary PCI.

Current DCB practice: from lesion preparation to follow-up

Left ventricle assist device for very high-risk PCI

21 May 2025 – From EuroPCR 2025

Discover the role of left ventricle assist devices in very high-risk PCI cases. This session features complex interventions combining Impella support, advanced imaging, rotational atherectomy, bifurcation and CTO techniques, and fully percutaneous ECMO-assisted procedures under local anesthesia.

Left ventricle assist device for very high-risk PCI

DES and DCB for bifurcation treatment

21 May 2025 – From EuroPCR 2025

Examine the use of drug-eluting stents (DES) and drug-coated balloons (DCB) in bifurcation lesion treatment. This session compares devices, analyses DAPT duration, and evaluates side branch optimization to inform best practices in bifurcation PCI.

DES and DCB for bifurcation treatment

Through decisions in complex left main PCI - Isolated ostial left circumflex

21 May 2025 – From EuroPCR 2025

Navigate complex isolated ostial left circumflex lesions with a focus on the integration of imaging and physiological assessment. Learn treatment options and optimisation strategies to improve long-term outcomes in left main PCI through detailed case presentations and expert guidance.

Through decisions in complex left main PCI - Isolated ostial left circumflex

Career and recognition for nurses and allied professionals in the cathlab: where are we?

21 May 2025 – From EuroPCR 2025

Explore the career landscape and recognition pathways for nurses and allied professionals in the cathlab. This session highlights workforce development, extraordinary career opportunities, and inspirational interviews to guide professional growth and empowerment.

Career and recognition for nurses and allied professionals in the cathlab: where are we?

Challenging vascular access and closure management

21 May 2025 – From EuroPCR 2025

Address challenging vascular access and closure management in complex TAVI cases. This session covers the selection of femoral access, use of PTA and intravascular lithotripsy, and strategies to manage closure failure with illustrative real-world cases.

Challenging vascular access and closure management

New diagnostic and therapeutical tools in the coronary field

21 May 2025 – From EuroPCR 2025

Explore the latest advancements in diagnostic and therapeutic tools in coronary interventions. This session covers a range of innovative topics including the prognostic impact of QFR-based complete versus incomplete revascularisation, hybrid perfusion quantification with cardiac CT and echocardiography, clinical validation of AI-assisted coronary angiography, national audit...

New diagnostic and therapeutical tools in the coronary field

Hotline TAVI 2: outcomes with new and established devices

21 May 2025 – From EuroPCR 2025

Review outcomes of new and established TAVI devices through pooled analyses and multicenter studies. Topics include comparisons of balloon-expandable valves, intra- versus supra-annular self-expanding valves, and insights from the ACURATE IDE and ACURATE prime studies.

Hotline TAVI 2: outcomes with new and established devices

TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3

21 May 2025 – From EuroPCR 2025

Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.

TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3

Redefining the red flags: early detection of myocardial infarction in women

22 May 2025 – From EuroPCR 2025

Gain a unique patient-centered perspective on early myocardial infarction detection in women. This session features a survivor's story, collaborative step-by-step clinical approaches, and key aspects of cardiac rehabilitation, emphasizing shared decision-making to improve patient outcomes in complex cases.

Redefining the red flags: early detection of myocardial infarction in women

LV support for very high risk PCI of calficied lesions

22 May 2025 – From EuroPCR 2025

Discover the role of left ventricular (LV) support in performing very high-risk PCI on heavily calcified lesions. This session highlights techniques for navigating complex calcified coronary anatomies using Impella support, strategies for metal casing reshaping, and management of acute MI and cardiac arrest scenarios. Explore alternative...

LV support for very high risk PCI of calficied lesions

PCI for complex calcific coronary artery disease - LIVE Case

22 May 2025 – From EuroPCR 2025

An 87-year-old female patient, at high bleeding risk and with preserved LV function, presented 2 months ago with an inferior STEMI and multivessel disease. She initially underwent RCA PCI followed by staged LCx PCI. She was now referred for PCI of a long, heavily calcified lesion...

PCI for complex calcific coronary artery disease - LIVE Case

Antiplatelet strategies for patients undergoing PCI

22 May 2025 – From EuroPCR 2025

Delve into this comprehensive session focusing on antiplatelet strategies for patients undergoing PCI. Explore evidence and clinical insights on ticagrelor monotherapy post-AMI stenting, shortened dual antiplatelet therapy (DAPT) durations, the role of CYP2C19 genotyping in stent thrombosis risk, the effectiveness of dual antithrombotic therapy in atrial...

Antiplatelet strategies for patients undergoing PCI

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

22 May 2025 – From EuroPCR 2025

Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation
Didn’t find what you were looking for?